Millie
your market intelligence analyst
Search Results
290 results
Your search is now limited to «Roche» expert search.
ENDPOINTS 07/19/2019 10:48
Let the long battle for biosimilars in the cancer space begin. Amgen has launched its Avastin and Herceptin copycats — licensed from the predecessors of Allergan — almost two years after the FDA had stamped its approval on (bevacizumab-awwb) and three months after the OK (trastuzumab-anns).
More from ENDPOINTS:
FiercePharmaManufacturing 07/19/2019 09:44
For years, Roche’s blockbuster oncology troika—Rituxan, Herceptin and Avastin—dominated sales stateside and abroad.
More from FiercePharmaManufacturing:
Hoffmann-La Roche (EU) 07/19/2019 04:00
Presentation slides will be posted on the Roche IR website.
More from Hoffmann-La Roche (EU):
PharmiWeb.com 07/19/2019 01:35
According to a newly published report by market.us, “Worldwide Myasthenia Gravis Drugs Market: Information About Key Drivers, Restraints, And Opportunities 2019-2028“. The prime objective of the report is to deliver a Ten-year (2019-2028) market forecast. The latest study focusing on myasthenia gravis drugs market with topmost companies, to determine, define and analyses the sales size, value, market share, market competition landscape, and recent development. It helps to decide a corporate, pro…
More from PharmiWeb.com:
Seeking Alpha 07/18/2019 10:00
Although the Spark deal is tied up, Roche continues to sign a range of development deals with small biotechs, and Roche recently announced three deals on the same day with Sosei Heptares, Convelo, and Skyhawk.
More from Seeking Alpha:
Reuters.com 07/18/2019 06:30
VALERITAS HOLDINGS INC:
More from Reuters.com:
PharmaTimes 07/17/2019 07:02
Sosei Heptares has announced a multi-target research collaboration and license agreement with Genentech, a member of the Roche Group, to discover and develop novel medicines that modulate G protein-coupled receptor (GPCR) targets of interest to Genentech.
More from PharmaTimes:
Bruno was visiting Les Roches on one of his regular recruiting missions.
More from Les Roches International School of Hotel Management:
Pharmafile 07/17/2019 05:48
Roche signs deal with Skyhawk over molecules that modulate RNA splicing.
More from Pharmafile:
Forbes 07/10/2019 15:52
As of 2018, the same drugs generated over $21 billion in revenues for Roche, and it appears that Roche’s acquisition of Genentech was a good deal, especially considering how it benefited Roche’s broader R&D direction.
More from Forbes:
PR Newswire 07/10/2019 08:07
About LA ROCHE-POSAY Recommended by 90,000 dermatologists worldwide, La Roche-Posay's mission is to offer a better life for sensitive skin.
More from PR Newswire:
Benzinga 07/09/2019 07:11
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks. (Biotech stocks hitting 52-week highs on July 8). Adverum Biotechnologies Inc (NASDAQ: ). Inspire Medical Systems Inc (NYSE: ) (announced UnitedHealth Group Inc (NYSE: ) coverage for Inspire therapy for the treatment of obstructive sleep apnea). Sol Gel Technologies Ltd (NASDAQ: )( positive results for late-stage trials that evaluated its Epsolay microencapsulated benzoyl peroxide cream, 5%, in papulopustular rosacea. Down In The Dumps. (Biotech stocks hitting 52-week lows on July 8). Advaxis, Inc. (NASDAQ: ). Aerie Pharmaceuticals Inc (NASDAQ: ). Atara Biotherapeutics Inc (NASDAQ: ). Evolent Health Inc (NYSE: ). Foamix Pharmaceuticals Ltd (NASDAQ: ).
More from Benzinga:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications